Sign In
Buy CBIO
$17.98
+0.98 (+5.73%)
At Close: Jun 03, 2026
Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and Vascular Biogenics (VBLT)
03:11am, Friday, 17'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biogen (BIIB) and Vascular Biogenics (VBLT) with bullish
Analysts Offer Insights on Healthcare Companies: Biogen (NASDAQ: BIIB) and Vascular Biogenics (NASDAQ: VBLT)
03:11am, Friday, 17'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biogen (BIIB
Impact of COVID-19 on the Global Digital PCR Industry - ResearchAndMarkets.com
03:44pm, Thursday, 16'th Apr 2020
The "Impact of COVID-19 on Global Digital PCR Industry" report has been added to ResearchAndMarkets.com's offering.
The Daily Biotech Pulse: FDA Nod For UroGen, Novavax Coronavirus Vaccine To Enter Clinics, Soligenix Licenses Vaccine Adjuvant
12:09pm, Thursday, 16'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 15.) * Bio-Rad Laboratories, Inc. Class B Common Stock
Analysts Offer Insights on Healthcare Companies: Staar Surgical Company (STAA), Planet 13 Holdings (OtherPLNHF) and PolarityTE (PTE)
10:17am, Tuesday, 14'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Staar Surgical Company (STAA), Planet 13 Holdings (PLNHF)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Staar Surgical Company (
STAA
–
Research Report
), Planet 13 Holdings (
PLNHF
–
Research Report
) a
Oppenheimer Remains a Buy on Athenex (ATNX)
01:39pm, Thursday, 09'th Apr 2020
In a report released today, Kevin DeGeeter from Oppenheimer maintained a Buy rating on Athenex (ATNX), with a price target of $23.00. The company's shares
Oppenheimer Remains a Buy on Athenex (ATNX)
01:39pm, Thursday, 09'th Apr 2020
In a report released today, Kevin DeGeeter from Oppenheimer maintained a Buy rating on Athenex (ATNX – Research Report), with
Novavax (NVAX) Received its Third Buy in a Row
01:29pm, Wednesday, 08'th Apr 2020
After Ladenburg Thalmann & Co. and Cantor Fitzgerald gave Novavax (NASDAQ: NVAX) a Buy rating last month, the company received another Buy, this time
Novavax (NVAX) Received its Third Buy in a Row
01:29pm, Wednesday, 08'th Apr 2020
After Ladenburg Thalmann & Co. and Cantor Fitzgerald gave Novavax (NASDAQ: NVAX) a Buy rating last month, the company received
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO) and PTC Therapeutics (PTCT)
10:14am, Wednesday, 08'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioNano Genomics (BNGO) and PTC Therapeutics (PTCT) with
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (NASDAQ: BNGO) and PTC Therapeutics (NASDAQ: PTCT)
10:14am, Wednesday, 08'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioNano Genomics
Catalyst Biosciences Announces Pivotal Phase 3 Study Design for MarzAA in Individuals with Hemophilia A or B with Inhibitors
12:00pm, Monday, 06'th Apr 2020
SOUTH SAN FRANCISCO, Calif., April 06, 2020 -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), a biopharmaceutical company that is developing novel subcutaneous (SQ) therapies for.
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Moleculin Biotech (MBRX
Analysts Are Bullish on These Healthcare Stocks: Vericel (VCEL), Immunomedics (IMMU)
05:28pm, Thursday, 02'nd Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vericel (VCEL) and Immunomedics (IMMU) with bullish
